Gestational Diabetes’ Impact on Babies: Malaga Study
- MÁLAGA, Spain — A team of researchers in Málaga has discovered that gestational diabetes not only affects the mother during pregnancy but also leaves a footprint on the...
- The findings come from a study by scientists at the Institute of Biomedical Research of Málaga and Plataforma en Nanomedicina (Ibima Plataforma Bionand), in collaboration with the Biomedical...
- The research indicates that maternal gestational diabetes can cause an epigenetic mark on the DNA of infants.
Gestational Diabetes Leaves Mark on Offspring DNA, Study Finds
Table of Contents
- Gestational Diabetes Leaves Mark on Offspring DNA, Study Finds
- Gestational Diabetes and Its Impact on Offspring: A Q&A
- What is gestational diabetes?
- What did the Málaga study discover about gestational diabetes?
- Where was this research conducted?
- What does “epigenetic alterations” mean, and why are thay critically important?
- What is DNA methylation?
- What is the connection between gestational diabetes and long-term health risks for the child?
- Who led this research?
- What is the EPI-DG study, and why is continued participation important?
- How can this research help in the future?
- Key Findings summary
MÁLAGA, Spain — A team of researchers in Málaga has discovered that gestational diabetes not only affects the mother during pregnancy but also leaves a footprint on the DNA of the baby, even if the child is born healthy.
The findings come from a study by scientists at the Institute of Biomedical Research of Málaga and Plataforma en Nanomedicina (Ibima Plataforma Bionand), in collaboration with the Biomedical Research Centre in Network in Physiopathology of Obesity and Nutrition (CIBEROBN). The study was published in the journal ‘Cardiovascular Diabetology.’
The research indicates that maternal gestational diabetes can cause an epigenetic mark on the DNA of infants. These changes in DNA methylation could influence their metabolic development and possibly increase the risk of diseases later in life, despite appearing healthy at birth.
Crucial Clue
“The discovery of these epigenetic alterations gives us a crucial clue about how gestational diabetes can leave a long-term mark on children’s health, even before metabolic diseases manifest in adulthood,” said Dr. Sonsoles Morcillo, Nicolás Monardes researcher, who led the study in collaboration with Dr. maría José Picón, Dr. María Molina, and Dr. Teresa Linares. The doctors all belong to group A-02 ‘Obesity, diabetes and its comorbidities: prevention and treatment,’ directed by Dr. Francisco J. Tinahones.
Researchers expressed their gratitude for the collaboration of the participants in the EPI-DG study and encouraged continued involvement in follow-up visits. “Each sample and each visit provide key data to advance the prevention of metabolic diseases in children,” the researchers noted.
“Understanding how prenatal factors affect long-term health is key to designing effective prevention programs,” said dr. Molina. “This study is one more step towards personalized preventive medicine from the first days of life.”
Ibima also affirmed its commitment to biomedical research aimed at addressing challenges of great social impact and improving the quality of life for the population.
Gestational Diabetes and Its Impact on Offspring: A Q&A
What is gestational diabetes?
Gestational diabetes is a type of diabetes that develops during pregnancy in women who did not have diabetes before. It usually occurs in the second or third trimester. The condition affects how your cells use sugar (glucose).It can frequently enough be controlled through diet and exercise, but sometimes medication is needed. (Source: Provided article)
What did the Málaga study discover about gestational diabetes?
The study,conducted by researchers in Málaga,Spain,found that gestational diabetes can leave a lasting “footprint” on a baby’s DNA. This occurs through epigenetic alterations, which are changes in DNA methylation that can effect how genes work. These changes can potentially increase the risk of metabolic diseases later in life, even if the child appears healthy at birth. (Source: Provided article)
Where was this research conducted?
The research was conducted at the Institute of Biomedical research of Málaga and Plataforma en Nanomedicina (Ibima Plataforma Bionand), in collaboration with the Biomedical Research Center in Network in Physiopathology of Obesity and Nutrition (CIBEROBN).(Source: Provided article)
What does “epigenetic alterations” mean, and why are thay critically important?
Epigenetic alterations refer to changes in gene expression caused by mechanisms other than changes in the underlying DNA sequence. These alterations, specifically DNA methylation in the context of the study, can influence how genes are “turned on” or “turned off.” In this study, researchers found that gestational diabetes caused these epigenetic marks in the baby’s DNA. This is significant as these marks could potentially affect the baby’s metabolic development and later health, even if the baby appears healthy at birth. (Source: Provided article)
What is DNA methylation?
DNA methylation is a biochemical process. It involves adding a methyl group to a cytosine base in the DNA molecule. This chemical “tag” can essentially modify the function of the DNA segment where it resides. It is one of the key ways epigenetic modifications are inherited.
What is the connection between gestational diabetes and long-term health risks for the child?
The study suggests that the epigenetic alterations caused by gestational diabetes may increase the child’s risk of developing metabolic diseases later in life. This could include conditions like type 2 diabetes, obesity, and other related health problems. The alterations may affect the baby’s metabolic development from the very beginning. (Source: Provided article)
Who led this research?
The study was led by Dr. Sonsoles Morcillo, a nicolás Monardes researcher. She collaborated with Dr. María José Picón, Dr. María Molina, and Dr. Teresa Linares. All of these doctors belong to group A-02 ‘Obesity, diabetes and its comorbidities: prevention and treatment,’ directed by Dr. Francisco J. Tinahones. (Source: Provided article)
What is the EPI-DG study, and why is continued participation important?
The EPI-DG study is a research project that involves participants in the study and gathers data to examine the effects of gestational diabetes. Researchers expressed their gratitude for the collaboration in the EPI-DG study, and encouraged participants to continue with follow-up visits. Further data gathered via future visits will provide key data to advance the prevention of metabolic diseases in children. (Source: Provided article)
How can this research help in the future?
The study provides crucial clues on how gestational diabetes affects the health of children, paving the way for effective prevention programs. Understanding the impact of prenatal factors can help design personalized preventive medicine strategies. (source: Provided article)
Key Findings summary
The following table summarizes the key findings of the study.
| Aspect | Details |
|---|---|
| condition Studied | Gestational Diabetes |
| Location of Research | Málaga, Spain (Ibima Plataforma Bionand) |
| Main Discovery | Gestational diabetes leads to epigenetic alterations in the offspring’s DNA. |
| Mechanism | changes in DNA methylation. |
| Potential Impact | Increased risk of metabolic diseases later in life, even with healthy birth. |